Journal of Drug Targeting

Papers
(The H4-Index of Journal of Drug Targeting is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Lauric acid-based thermosensitive delivery system for the treatment of head and neck squamous cell carcinoma58
Advancement in transporter-oriented nanoplatforms for cancer therapy49
Advances in targeted therapy for triple-negative breast cancer: a review of key antigens and recent advances48
Polymyxin B Delivery Systems: Smart Solutions for Improved Antibacterial Activity and Reduced Toxicity47
Resveratrol in ulcerative colitis: therapeutic mechanisms, animal model evidence and novel approaches42
Cancer cell membrane camouflaging mesoporous nanoplatform interfering with cellular redox homeostasis to amplify photodynamic therapy on oral carcinoma36
Methods for fabricating oxygen releasing biomaterials33
Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis32
Significant metabolic alterations in patients with hepatitis B virus replication observed via serum untargeted metabolomics shed new light on hepatitis B virus infection30
Nose-to-brain delivery of transferrin-modified carmustine-loaded iron nanoparticles for enhanced glioblastoma treatment28
Role of curcumin and its nanoformulations in the treatment of neurological diseases through the effects on stem cells27
Novel strategies for the fight of Alzheimer’s disease targeting amyloid-β protein27
Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases26
Correction26
Improved antidiabetic potential of quercetin-loaded chitosan–lecithin nanoparticles for effective glycaemic control24
Advances in nanomedicine for retinal drug delivery: overcoming barriers and enhancing therapeutic outcomes23
Effect of Malt-PEG-Abz@RSL3 micelles on HepG2 cells based on NADPH depletion and GPX4 inhibition in ferroptosis22
Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer21
Correction20
Exosomes derived from cancer cells relieve inflammatory bowel disease in mice20
Emerging role of ferroptosis in diabetic retinopathy: a review20
Sequential targeting dual-responsive magnetic nanoparticle for improved therapy of lung metastatic breast cancer20
0.029254913330078